+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Morphine Market Outlook 2026-2034: by Dosage Form (Injection, Oral Tablets / Capsules, Oral Solution / Drops, Suppositories), Route of Administration, Application, End-User- Product Image
Morphine Market Outlook 2026-2034: by Dosage Form (Injection, Oral Tablets / Capsules, Oral Solution / Drops, Suppositories), Route of Administration, Application, End-User- Product Image
Sale

Morphine Market Outlook 2026-2034: by Dosage Form (Injection, Oral Tablets / Capsules, Oral Solution / Drops, Suppositories), Route of Administration, Application, End-User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6243479
UP TO OFF until Jan 01st 2027
Description Jump to:
The Morphine Market is estimated at US$34.3 billion in 2026 and is projected to grow at a CAGR of 6.9% to reach US$58.5 billion by 2034.

Market Overview

The Morphine Market covers morphine based pharmaceutical products used for pain management across acute, postoperative, palliative, and hospital controlled treatment settings.

Relevant uses and settings include hospital pain control, palliative care, surgical recovery, emergency medicine, oncology support, and regulated pharmacy channels. Commercial considerations include opioid regulation, misuse concerns, supply controls, safety monitoring burdens, and growing preference for alternative pain strategies where appropriate.

Market Segmentation

By Dosage Form

  • Injection
  • Oral Tablets / Capsules
  • Oral Solution / Drops
  • Suppositories

By Route of Administration

  • Intravenous
  • Intramuscular / Sub-cutaneous
  • Epidural
  • Intrathecal

By Application

  • Pain Management
  • Cancer Pain
  • Neuropathic Pain
  • Osteoarthritis & Musculoskeletal Pain
  • Other Pain Segments
  • Diarrhoea Suppression
  • Cough Suppression
  • Adjunct to Anaesthesia

By End-User

  • Hospitals
  • Retail Pharmacies
  • Home-Care / Hospice Centres
  • Online Pharmacies

Key Companies Analysed

  • Alkaloid AD
  • Mallinckrodt Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Mundipharma
  • Purdue Pharma
  • Hikma Pharmaceuticals
  • Johnson Matthey
  • Mayne Pharma
  • Viatris
  • Teva Pharmaceutical Industries
  • Pfizer
  • Boehringer Ingelheim
  • Fresenius Kabi
  • Sanofi
  • Macleods Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Taj Pharmaceuticals
  • Neon Laboratories
  • Aurobindo Pharma
  • Hospira

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Morphine Market Overview
2.1. Morphine Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Morphine Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Morphine Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Morphine Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Morphine Market Analysis By Dosage Form, 2025-2034
5.2.1. Injection
5.2.2. Oral Tablets / Capsules
5.2.3. Oral Solution / Drops
5.2.4. Suppositories
5.3. Morphine Market Analysis By Route of Administration, 2025-2034
5.3.1. Intravenous
5.3.2. Intramuscular / Sub-cutaneous
5.3.3. Epidural
5.3.4. Intrathecal
5.4. Morphine Market Analysis By Application, 2025-2034
5.4.1. Pain Management
5.4.2. Cancer Pain
5.4.3. Neuropathic Pain
5.4.4. Osteoarthritis & Musculoskeletal Pain
5.4.5. Other Pain Segments
5.4.6. Diarrhoea Suppression
5.4.7. Cough Suppression
5.4.8. Adjunct to Anaesthesia
5.5. Morphine Market Analysis By End-User, 2025-2034
5.5.1. Hospitals
5.5.2. Retail Pharmacies
5.5.3. Home-Care / Hospice Centres
5.5.4. Online Pharmacies
6. North America Morphine Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Morphine Market Analysis By Dosage Form
6.3. North America Morphine Market Analysis By Route of Administration
6.4. North America Morphine Market Analysis By Application
6.5. North America Morphine Market Analysis By End-User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Morphine Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Morphine Market Analysis By Dosage Form
7.3. Europe Morphine Market Analysis By Route of Administration
7.4. Europe Morphine Market Analysis By Application
7.5. Europe Morphine Market Analysis By End-User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Morphine Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Morphine Market Analysis By Dosage Form
8.3. Asia-Pacific Morphine Market Analysis By Route of Administration
8.4. Asia-Pacific Morphine Market Analysis By Application
8.5. Asia-Pacific Morphine Market Analysis By End-User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Morphine Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Morphine Market Analysis By Dosage Form
9.3. Middle East and Africa Morphine Market Analysis By Route of Administration
9.4. Middle East and Africa Morphine Market Analysis By Application
9.5. Middle East and Africa Morphine Market Analysis By End-User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Morphine Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Morphine Market Analysis By Dosage Form
10.3. South and Central America Morphine Market Analysis By Route of Administration
10.4. South and Central America Morphine Market Analysis By Application
10.5. South and Central America Morphine Market Analysis By End-User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Morphine Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Alkaloid AD
11.2.2. Mallinckrodt Pharmaceuticals
11.2.3. Sun Pharmaceutical Industries
11.2.4. Mundipharma
11.2.5. Purdue Pharma
11.2.6. Hikma Pharmaceuticals
11.2.7. Johnson Matthey
11.2.8. Mayne Pharma
11.2.9. Viatris
11.2.10. Teva Pharmaceutical Industries
11.2.11. Pfizer
11.2.12. Boehringer Ingelheim
11.2.13. Fresenius Kabi
11.2.14. Sanofi
11.2.15. Macleods Pharmaceuticals
11.2.16. Glenmark Pharmaceuticals
11.2.17. Taj Pharmaceuticals
11.2.18. Neon Laboratories
11.2.19. Aurobindo Pharma
11.2.20. Hospira
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Alkaloid AD
  • Mallinckrodt Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Mundipharma
  • Purdue Pharma
  • Hikma Pharmaceuticals
  • Johnson Matthey
  • Mayne Pharma
  • Viatris
  • Teva Pharmaceutical Industries
  • Pfizer
  • Boehringer Ingelheim
  • Fresenius Kabi
  • Sanofi
  • Macleods Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Taj Pharmaceuticals
  • Neon Laboratories
  • Aurobindo Pharma
  • Hospira

Table Information

Report AttributeDetails
No. of Pages160
PublishedOctober 2026
Forecast Period2026 - 2034
Estimated Market Value ( USD ) in 2026 $ 34.3 Billion
Forecasted Market Value ( USD ) by 2034 $ 58.5 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Morphine Drugs Market Report 2026 - Product Image

Morphine Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Medical Morphine Market Outlook 2026-2034: Market Size, Share and Growth Analysis - Product Image

Medical Morphine Market Outlook 2026-2034: Market Size, Share and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Morphine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Morphine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Morphine Drugs - Global Strategic Business Report - Product Image

Morphine Drugs - Global Strategic Business Report

  • Report
  • 469 Pages
  • Global
From
Morphine Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Morphine Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.